Menu

Atossa Therapeutics, Inc. ATOS

Full chart Compare
Set alert

Price alert · ATOS

All alert types
2.12 USD +0.10 (+4.95%)

At closeNov 9, 2026, 8:13 AM EST

2.20 +0.08 +3.77%

Pre-market · Nov 9, 8:13 AM ET

1.99 Day range 2.19
1.70 52-week range 14.85
YTD
-76.05%
1 year
-82.55%

Revenue & Expenses

Net Loss → Expenses: $15.76MExpenses → Gross Loss: $130.65KExpenses → Selling, General & Admin: $10.27MExpenses → Research & Development: $2.36MExpenses → Other Expenses: $3.00MRevenue → Cost of Revenue: $1.76KNet Loss$15.76MCost of Revenue$132.41KExpenses$15.76MGross Loss$130.65KSelling, General & Admin$10.27MResearch & Development$2.36MOther Expenses$3.00MRevenue$1.76K

Latest period ending Dec 31, 2025 · select a line to chart its full history

ATOS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-37.14M-27.62M-31.38M-27.69M-20.52M
-34.77M-25.50M-30.09M-26.96M-20.61M
-4.04-3.04-3.60-3.15-2.70
ATOS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
41.41M71.19M88.57M111.00M136.49M
47.61M76.44M96.25M123.53M141.26M
8.26M4.97M5.24M5.57M3.13M
39.35M71.48M91.02M117.96M138.14M
ATOS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-29.76M-21.03M-20.94M-20.76M-16.47M
-23.00K-19.00K-14.00K-4.73M-9.00K
-23.00K-19.00K-14.00K-27.00K-9.00K
-29.79M-17.38M-22.43M-25.49M96.82M